Press Release: Nuvectra : Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis

PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted...